Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Response by Schiavon et al to Letters Regarding Article, "Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension)".

Schiavon CA, Ikeoka D, Santucci EV, Santos RN, Damiani LP, Cavalcanti AB, Drager LF.

Circulation. 2018 Oct 2;138(14):1492-1493. doi: 10.1161/CIRCULATIONAHA.118.036015. No abstract available.

PMID:
30354352
2.

Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).

Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, Frayha JC, Santos RN, Damiani LP, Noujaim PM, Halpern H, Monteiro FLJ, Cohen RV, Uchoa CH, de Souza MG, Amodeo C, Bortolotto L, Ikeoka D, Drager LF, Cavalcanti AB, Berwanger O.

Circulation. 2018 Mar 13;137(11):1132-1142. doi: 10.1161/CIRCULATIONAHA.117.032130. Epub 2017 Nov 13.

3.

Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: The Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose (LOAD) randomized trial.

Berwanger O, de Barros E Silva PG, Barbosa RR, Precoma DB, Figueiredo EL, Hajjar LA, Kruel CD, Alboim C, Almeida AP, Dracoulakis MD, Filho HV, Carmona MJ, Maia LN, de Oliveira Filho JB, Saraiva JF, Soares RM, Damiani L, Paisani D, Kodama AA, Gonzales B, Ikeoka DT, Devereaux PJ, Lopes RD; LOAD Investigators.

Am Heart J. 2017 Feb;184:88-96. doi: 10.1016/j.ahj.2016.11.001. Epub 2016 Nov 9.

PMID:
27892891
4.

The Role of Metabolic Surgery on Blood Pressure Control.

Schiavon CA, Drager LF, Bortolotto LA, Amodeo C, Ikeoka D, Berwanger O, Cohen RV.

Curr Atheroscler Rep. 2016 Aug;18(8):50. doi: 10.1007/s11883-016-0598-x. Review.

PMID:
27324638
5.

Effects of gastric bypass surgery in patients with hypertension: rationale and design for a randomised controlled trial (GATEWAY study).

Schiavon CA, Ikeoka DT, de Sousa MG, Silva CR, Bersch-Ferreira AC, de Oliveira JD, Noujaim PM, Cohen RV, Amodeo C, Berwanger O; GATEWAY (GAstric bypass surgery to TrEat patients With steAdy hYpertension) Investigators.

BMJ Open. 2014 Sep 8;4(9):e005702. doi: 10.1136/bmjopen-2014-005702.

6.

Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.

Bernardez-Pereira S, Lopes RD, Carrion MJ, Santucci EV, Soares RM, de Oliveira Abreu M, Laranjeira LN, Ikeoka DT, Zazula AD, Moreira FR, Cavalcanti AB, Mesquita ET, Peterson ED, Califf RM, Berwanger O; Methodological Evaluation of clinical TriAls Study Group.

Am Heart J. 2014 Aug;168(2):213-9.e1. doi: 10.1016/j.ahj.2014.04.013. Epub 2014 May 2.

PMID:
25066561
7.

Evaluation of the Society of Thoracic Surgeons score system for isolated coronary bypass graft surgery in a Brazilian population.

Ikeoka DT, Fernandes VA, Gebara O, Garcia JC, Barros e Silva PG, Rodrigues MJ, Furlan V, Baruzzi AC.

Rev Bras Cir Cardiovasc. 2014 Jan-Mar;29(1):51-8.

8.

Intravenous thrombolysis in basilar dissection: report of a good recovery and follow-up.

Kuster GW, Baruzzi AC, Ikeoka D, Pieruccetti M, Furlan V.

Arq Neuropsiquiatr. 2014 Jan;72(1):86-7. doi: 10.1590/0004-282X20130208. No abstract available.

9.

End of life and palliative care in intensive care.

Baruzzi AC, Ikeoka DT.

Rev Assoc Med Bras (1992). 2013 Nov-Dec;59(6):528-30. doi: 10.1016/j.ramb.2013.06.018. Epub 2013 Nov 16. English, Portuguese. No abstract available.

10.

Implementation of an institutional protocol for rational use of blood products and its impact on postoperative of coronary artery bypass graft surgery.

Silva PG, Ikeoka DT, Fernandes VA, Lasta NS, Silva DP, Okada MY, Izidoro BA, Garcia JC, Baruzzi AC, Furlan V.

Einstein (Sao Paulo). 2013 Jul-Sep;11(3):310-6. English, Portuguese.

11.

Effects of intermittent fasting on metabolism in men.

Azevedo FR, Ikeoka D, Caramelli B.

Rev Assoc Med Bras (1992). 2013 Mar-Apr;59(2):167-73. doi: 10.1016/j.ramb.2012.09.003. Review.

12.

II Guidelines for perioperative evaluation of the Brazilian Society of Cardiology.

Gualandro DM, Yu PC, Calderaro D, Marques AC, Pinho C, Caramelli B, Feitosa AC, Ayub B, Polanczyk CA, Jardim C, Vieira CL, lezzi D, Ikeoka DT, Schreen D, D'Amico EA, Pfeferman E, de Lima EQ, Burdmann Ede A, Pachon E, Machado FS, Galas FR, Paula FJ, Carvalho FC, Feitosa-Filho GS, Prado GF, Lopes HF, Lima JJ, Marchini JF, Fornari LS, Drager LF, Vacanti LJ, Hajjar LA, Rohde LE, Gowdak LH, Cardoso LF, Vieira ML, Monachini MC, Macatrão M, Villaça PR, Farsky PS, Lopes RD, Bagnatori RS, Heinisch RH, Gualandro SF, Accorsi TA, Avila WS, Mathias W Jr.

Arq Bras Cardiol. 2011;96(3 Suppl 1):1-68. English, Portuguese. No abstract available.

13.

Lipid-heparin infusion suppresses the IL-10 response to trauma in subcutaneous adipose tissue in humans.

Ikeoka DT, Pachler C, Mader JK, Bock G, Neves AL, Svehlikova E, Feichtner F, Koehler G, Wrighton CJ, Pieber TR, Ellmerer M.

Obesity (Silver Spring). 2011 Apr;19(4):715-21. doi: 10.1038/oby.2010.227. Epub 2010 Nov 18.

14.

Assessment of different techniques for subcutaneous glucose monitoring in Type 1 diabetic patients during 'real-life' glucose excursions.

Mader JK, Weinhandl H, Köhler G, Plank J, Bock G, Korsatko S, Ratzer M, Ikeoka D, Köhler H, Pieber TR, Ellmerer M.

Diabet Med. 2010 Mar;27(3):332-8. doi: 10.1111/j.1464-5491.2009.02924.x.

PMID:
20536497
15.

Adipose tissue, inflammation and cardiovascular disease.

Ikeoka D, Mader JK, Pieber TR.

Rev Assoc Med Bras (1992). 2010 Jan-Feb;56(1):116-21. Review.

16.

Interleukin-6 produced in subcutaneous adipose tissue is linked to blood pressure control in septic patients.

Ikeoka D, Pachler C, Korsatko S, Mader JK, Weinhandl H, Bodenlenz M, Plank J, Smolle KH, Ellmerer M, Pieber TR.

Cytokine. 2010 Jun;50(3):284-91. doi: 10.1016/j.cyto.2010.02.015. Epub 2010 Mar 19.

PMID:
20303782
17.

Clinical evaluation of subcutaneous lactate measurement in patients after major cardiac surgery.

Ellmerer M, Haluzik M, Blaha J, Kremen J, Svacina S, Plasnik A, Ikeoka D, Bodenlenz M, Schaupp L, Plank J, Pieber TR.

Int J Endocrinol. 2009;2009:390975. doi: 10.1155/2009/390975. Epub 2009 May 26.

18.

Insulin resistance and lipid metabolism.

Ikeoka D, Krusinova E.

Rev Assoc Med Bras (1992). 2009 May-Jun;55(3):234. No abstract available.

19.

Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.

Ikeoka DT, Vieira CZ, Lemos PA, Strabelli TV, da Silva EE, Perin MA, Groselj-Strele A, Tiran B, Tiran A, Caramelli B.

Clin Res Cardiol. 2009 Jan;98(1):44-51. doi: 10.1007/s00392-008-0722-1. Epub 2008 Oct 13.

PMID:
18853090
20.

Physiological hyperinsulinemia has no detectable effect on access of macromolecules to insulin-sensitive tissues in healthy humans.

Weinhandl H, Pachler C, Mader JK, Ikeoka D, Mautner A, Falk A, Suppan M, Pieber TR, Ellmerer M.

Diabetes. 2007 Sep;56(9):2213-7. Epub 2007 Jun 29.

Supplemental Content

Loading ...
Support Center